October Pharma S.A.E (EGX:OCPH)

Market Cap	2.40B
Revenue (ttm)	1.46B
Net Income (ttm)	165.09M
Shares Out	12.00M
EPS (ttm)	13.76
PE Ratio	14.53
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,640
Average Volume	11,401
Open	200.73
Previous Close	200.73
Day's Range	198.15 - 204.20
52-Week Range	87.32 - 249.88
Beta	0.23
RSI	47.93
Earnings Date	Apr 8, 2026

About October Pharma S.A.E

October Pharma S.A.E manufactures and sells pharmaceutical products in Egypt. The company provides its products in solid forms, such as tablets, capsules, and powders; liquid forms comprising syrups, drops, solutions, and sprays; creams and suppositories; soft gelatin capsules; and ampoules and vials. October Pharma S.A.E was founded in 1987 is based in Cairo, Egypt.

• Industry: Pharmaceutical Preparations
• Founded: 1987
• Country: Egypt
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: OCPH

Financial Performance

In 2024, October Pharma S.A.E's revenue was 1.23 billion, an increase of 21.39% compared to the previous year's 1.01 billion. Earnings were 131.26 million, a decrease of -12.72%.